Tracking Medicare news, policy, and coverage changes.
After the Trump administration on Tuesday released its annual report on Social Security and its projected future, officials from AARP urged action to protect the program. The annual report from the board of trustees of Social Security and Medicare stated that Social Security’s Old-Age and Survivors Insurance (OASI) Trust Fund will be able to pay...
Read full article →GSK’s Nuvalent acquisition brings two lead programs, each addressing different targets for non-small cell lung cancer. The Nuvalent lung cancer drugs are under FDA review and if they’re approved, GSK plans to launch both this year. The post GSK Gets a Pair of Near-Commercial Lung Cancer Drugs via $10.6B Nuvalent Acquisition appeared first on MedCity News .
Read full article →Plus a buried alcohol study gets published, and a Biosecure update.
Read full article →The condemnations keep coming after five diabetes experts were escorted out of an ADA meeting for handing out copies of an editorial criticizing federal research cuts.
Read full article →Federal health regulators on Tuesday signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years.
Read full article →The Trump administration has warned more than 500 hospitals that they are failing to provide the public with basic pricing information.
Read full article →AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The Readout
Read full article →The NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.
Read full article →Opinions are divided about the new facility in Kenya. The U.S. defends it. Kenyans are protesting it. Doctors who were on the ground in the 2014 Ebola outbreak voice criticism as well.
Read full article →Research published in the American Journal of Public Health details the connection between ultra-processed foods and the tobacco industry when it comes to production, strategy and marketing.
Read full article →(MedPage Today) -- Investigational apitegromab -- a selective myostatin activation inhibitor -- effectively preserved lean mass when combined with tirzepatide (Zepbound) in a randomized phase II trial, suggesting it could help fight "Ozempic...
Read full article →(MedPage Today) -- The Trump administration has warned more than 500 hospitals that they are failing to provide the public with basic pricing information -- arguing that the lack of disclosure is keeping healthcare costs higher than they should...
Read full article →